Table 1.
Clinical features of PBC patients and HCs in this study.
| PBC (n=35) | HC (n=37) | (P values) | |
|---|---|---|---|
| Age (years) | 50.91 ± 1.42 | 52.59 ± 1.19 | 0.24 |
| Males/females | 2/33 | 2/35 | – |
| Mayo risk score | 3.41 (3.06, 3.79) | – | – |
| Total protein (g/L) | 80.48 ± 1.01 | 74.43 ± 0.67 | 1.20E-5 |
| Globulin (g/L) | 34.53 ± 1.24 | 26.91 ± 0.55 | 1.34E-6 |
| ALT (U/L) | 33.44 ± 3.07 | 17.59 ± 1.59 | 3.68E-5 |
| AST (U/L) | 44.56 ± 5.11 | 19.5 ± 0.99 | 3.12E-05 |
| ALP (U/L) | 157.97 ± 16.11 | 74.86 ± 5.25 | 1.85E-5 |
| Total bilirubin (mg/dL) | 0.85 (0.61, 1.17) | 0.58 (0.41, 0.73) | 1.00E-03 |
| Direct bilirubin (mg/dL) | 0.29 (0.18, 0.39) | 0.18 (0.12, 0.29) | 3.90E-02 |
| Indirect bilirubin (mg/dL) | 0.68 ± 0.07 | 0.38 ± 0.01 | 4.45E-04 |
| GGT (U/L) | 154.72 ± 31.85 | 18.77 ± 1.98 | 1.74E-04 |
| Eosinophil (%) | 2.55 ± 0.44 | 1.38 ± 0.15 | 1.70E-02 |
| Eosinophil (109/L) | 0.13 ± 0.02 | 0.07 ± 0.01 | 1.59E-02 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; GGT, γ-glutamyl transpeptidase.